5,6,7,8-tetrahydro-4h-isoxazolo(4,5-d)azepin-3-ol has been researched along with mdl 11939 in 1 studies
| Studies (5,6,7,8-tetrahydro-4h-isoxazolo(4,5-d)azepin-3-ol) | Trials (5,6,7,8-tetrahydro-4h-isoxazolo(4,5-d)azepin-3-ol) | Recent Studies (post-2010) (5,6,7,8-tetrahydro-4h-isoxazolo(4,5-d)azepin-3-ol) | Studies (mdl 11939) | Trials (mdl 11939) | Recent Studies (post-2010) (mdl 11939) |
|---|---|---|---|---|---|
| 5 | 0 | 1 | 41 | 1 | 14 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frølund, B; Gloriam, DE; Isberg, V; Jensen, AA; Krall, J; Krogsgaard-Larsen, P; Pedersen, MH; Plath, N; Stensbøl, TB; Wellendorph, P | 1 |
1 other study(ies) available for 5,6,7,8-tetrahydro-4h-isoxazolo(4,5-d)azepin-3-ol and mdl 11939
| Article | Year |
|---|---|
Design, synthesis, and pharmacological characterization of N- and O-substituted 5,6,7,8-tetrahydro-4H-isoxazolo[4,5-d]azepin-3-ol analogues: novel 5-HT(2A)/5-HT(2C) receptor agonists with pro-cognitive properties.
Topics: Azepines; Biological Availability; Cognition; Drug Design; HEK293 Cells; Humans; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Serotonin Receptor Agonists | 2013 |